日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma.

双重 ALK/FAK 抑制剂 ESK440 在 ALK 驱动的神经母细胞瘤中的治疗益处

Chugh Seema, Tien Jean C, Hon Jennifer, Kenum Carson, Mannan Rahul, Cheng Yunhui, Li Chi Chiang, Taher Zainab I, Delekta Andrew D, Bawa Pushpinder Singh, Apel Ingrid J, Miner Stephanie J, Cao Xuhong, Mehra Rohit, Dhanasekaran Saravana M, Qiao Yuanyuan, Mody Rajen, Chinnaiyan Arul M

Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer

作者更正:靶向增强子依赖型前列腺癌中的SWI/SNF ATP酶

Xiao, Lanbo; Parolia, Abhijit; Qiao, Yuanyuan; Bawa, Pushpinder; Eyunni, Sanjana; Mannan, Rahul; Carson, Sandra E; Chang, Yu; Wang, Xiaoju; Zhang, Yuping; Vo, Josh N; Kregel, Steven; Simko, Stephanie A; Delekta, Andrew D; Jaber, Mustapha; Zheng, Heng; Apel, Ingrid J; McMurry, Lisa; Su, Fengyun; Wang, Rui; Zelenka-Wang, Sylvia; Sasmal, Sanjita; Khare, Leena; Mukherjee, Subhendu; Abbineni, Chandrasekhar; Aithal, Kiran; Bhakta, Mital S; Ghurye, Jay; Cao, Xuhong; Navone, Nora M; Nesvizhskii, Alexey I; Mehra, Rohit; Vaishampayan, Ulka; Blanchette, Marco; Wang, Yuzhuo; Samajdar, Susanta; Ramachandra, Murali; Chinnaiyan, Arul M